`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`Apotex, Inc.,
`
`Petitioner,
`
`v.
`
`UCB BIOPHARMA SPRL
`
`Patent Owner.
`
`Case IPR2019-00400
`U.S. Patent No. 8,633,194
`Title: Pharmaceutical composition of piperazine derivatives
`
`PETITIONER’S UPDATED MANDATORY NOTICE INFORMATION
`UNDER 37 C.F.R. § 42.8
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`US_138464844v1_338625-00067
`
`1
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194 B2
`Pursuant to 37 C.F.R. § 42.8(a)(3), Petitioner, Apotex, Inc. (“Apotex”),
`
`hereby submits the following updated mandatory notices:
`
`B. Notice of Related Matters (37 C.F.R. § 42.8(b)(2))
`1.
`Judicial Matters Involving the ’194 Patent
`The ’194 patent is currently the subject of the following litigation: UCB, Inc.
`
`et al. v. Apotex Inc., No. 0-18-cv-60846 (S.D. Fla.). On April 1, 2019, Judge Cooke
`
`of the Southern District of Florida issued an Order staying that case pending the
`
`PTAB’s Inter Partes Review of the ’194 patent.
`
`
`
`
`
`
`
`
`Dated: April 2, 2019
`
`Respectfully submitted,
`
`/s/ Jitendra Malik
`Jitendra Malik, Ph.D.
`Alissa M. Pacchioli
`Joseph M. Janusz
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`jitty.malik@kattenlaw.com
`alissa.pacchioli@kattenlaw.com
`joe.janusz@kattenlaw.com
`
`
`Lance Soderstrom
`Katten Muchin Rosenman LLP
`575 Madison Avenue
`New York, NY 10022-2585
`lance.soderstrom@kattenlaw.com
`
`Counsel for Apotex, Inc.
`
`US_138464844v1_338625-00067
`
`2
`
`
`
`IPR2019-00400
`Patent 8,633,194 B2
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6 and 42.105, I hereby certify that on this 2nd day
`
`of April, 2019, the foregoing Petitioner’s Updated Mandatory Notice Information
`
`Under 37 C.F.R. § 42.8 was served by filing this document through the Patent Trial
`
`and Appeal Board End to End System, as well as delivering a copy via electronic
`
`mail upon the following attorneys of record for the Petitioner:
`
`James S. Trainor
`Robert E. Counihan
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, NY 10010
`jtrainor@fenwick.com
`rcounihan@fenwick.com
`
`Erica R. Sutter
`Fenwick & West LLP
`801 California St.
`Mountain View, CA 94041
`esutter@fenwick.com
`
`Date: April 2, 2019
`
`Respectfully submitted,
`
`/s/ Jitendra Malik (Electronically signed)
`Jitendra Malik (Reg. No. 55,823)
`
`Counsel for Apotex, Inc.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`US_138464844v1_338625-00067
`
`3
`
`